Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (6): 567-571.DOI: 10.3969/j.issn.1673-8640.2018.06.021
Previous Articles Next Articles
ZHU Jun, YANG Xue, LOU Jiao, XU Chong()
Received:
2018-01-20
Online:
2018-06-30
Published:
2018-07-06
CLC Number:
ZHU Jun, YANG Xue, LOU Jiao, XU Chong. Investigation and analysis on quality indicators for clinical laboratories in Shanghai[J]. Laboratory Medicine, 2018, 33(6): 567-571.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.06.021
质量指标 | 实验室数(个) | 百分比(%) | σ水平 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
总体 | P5 | P50 | P95 | 总体 | P5 | P50 | P95 | |||
标本类型错误率 | 161 | 0.03 | 0.00 | 0.00 | 0.13 | 5.47 | 4.51 | 5.48 | 6.00 | |
标本容器错误率 | 161 | 0.01 | 0.00 | 0.00 | 0.08 | 5.55 | 4.66 | 5.60 | 6.00 | |
标本采集量错误率 | 161 | 0.04 | 0.00 | 0.01 | 0.18 | 5.34 | 4.41 | 5.28 | 6.00 | |
抗凝标本凝集率 | 159 | 0.11 | 0.00 | 0.03 | 0.58 | 5.01 | 4.00 | 4.93 | 6.00 | |
血培养污染率 | 126 | 1.58 | 0.00 | 0.24 | 6.70 | 4.53 | 1.81 | 4.19 | 6.00 | |
检验报告不正确率 | 153 | 0.01 | 0.00 | 0.00 | 0.06 | 5.81 | 4.72 | 6.00 | 6.00 | |
危急值通报率 | 148 | 98.94 | 96.12 | 100.00 | 100.00 | 5.75 | 3.34 | 6.00 | 6.00 | |
危急值通报及时率 | 142 | 97.90 | 85.82 | 100.00 | 100.00 | 5.45 | 2.57 | 6.00 | 6.00 | |
室内质控项目开展率 | 110 | 79.83 | 36.62 | 84.95 | 100.00 | 3.08 | 1.61 | 2.53 | 6.00 | |
室内质控项目CV不合格率 | 105 | 3.60 | 0.00 | 0.00 | 15.46 | 4.81 | 2.57 | 6.00 | 6.00 | |
室间质评项目参加率 | 101 | 97.44 | 85.01 | 100.00 | 100.00 | 5.35 | 2.53 | 6.00 | 6.00 | |
室间质评项目不合格率 | 101 | 0.63 | 0.00 | 0.00 | 3.11 | 5.18 | 3.37 | 6.00 | 6.00 | |
实验室间比对率 | 93 | 45.91 | 3.75 | 30.30 | 100.00 | 2.10 | 0.00 | 0.98 | 6.00 |
质量指标 | 实验室数(个) | 百分比(%) | σ水平 | |||||||
---|---|---|---|---|---|---|---|---|---|---|
总体 | P5 | P50 | P95 | 总体 | P5 | P50 | P95 | |||
标本类型错误率 | 161 | 0.03 | 0.00 | 0.00 | 0.13 | 5.47 | 4.51 | 5.48 | 6.00 | |
标本容器错误率 | 161 | 0.01 | 0.00 | 0.00 | 0.08 | 5.55 | 4.66 | 5.60 | 6.00 | |
标本采集量错误率 | 161 | 0.04 | 0.00 | 0.01 | 0.18 | 5.34 | 4.41 | 5.28 | 6.00 | |
抗凝标本凝集率 | 159 | 0.11 | 0.00 | 0.03 | 0.58 | 5.01 | 4.00 | 4.93 | 6.00 | |
血培养污染率 | 126 | 1.58 | 0.00 | 0.24 | 6.70 | 4.53 | 1.81 | 4.19 | 6.00 | |
检验报告不正确率 | 153 | 0.01 | 0.00 | 0.00 | 0.06 | 5.81 | 4.72 | 6.00 | 6.00 | |
危急值通报率 | 148 | 98.94 | 96.12 | 100.00 | 100.00 | 5.75 | 3.34 | 6.00 | 6.00 | |
危急值通报及时率 | 142 | 97.90 | 85.82 | 100.00 | 100.00 | 5.45 | 2.57 | 6.00 | 6.00 | |
室内质控项目开展率 | 110 | 79.83 | 36.62 | 84.95 | 100.00 | 3.08 | 1.61 | 2.53 | 6.00 | |
室内质控项目CV不合格率 | 105 | 3.60 | 0.00 | 0.00 | 15.46 | 4.81 | 2.57 | 6.00 | 6.00 | |
室间质评项目参加率 | 101 | 97.44 | 85.01 | 100.00 | 100.00 | 5.35 | 2.53 | 6.00 | 6.00 | |
室间质评项目不合格率 | 101 | 0.63 | 0.00 | 0.00 | 3.11 | 5.18 | 3.37 | 6.00 | 6.00 | |
实验室间比对率 | 93 | 45.91 | 3.75 | 30.30 | 100.00 | 2.10 | 0.00 | 0.98 | 6.00 |
质量指标 | 三级医院 | 二级医院 | 二级以下医院 | P值 | |||||
---|---|---|---|---|---|---|---|---|---|
实验 室数(个) | P50(P5~P95) | 实验室数(个) | P50(P5~P95) | 实验室数(个) | P50(P5~P95) | ||||
标本类型错误率 | 46 | 0.00(0.00~0.06) | 91 | 0.00(0.00~0.13) | 24 | 0.00(0.00~0.29) | 0.29 | ||
标本容器错误率 | 46 | 0.00(0.00~0.05) | 91 | 0.00(0.00~0.10) | 24 | 0.00(0.00~0.11) | 0.01 | ||
标本采集量错误率 | 46 | 0.00(0.00~0.23) | 91 | 0.01(0.00~0.18) | 24 | 0.00(0.00~0.20) | 0.00 | ||
抗凝标本凝集率 | 46 | 0.05(0.01~1.07) | 89 | 0.03(0.00~0.60) | 24 | 0.00(0.00~0.85) | 0.01 | ||
血培养污染率 | 43 | 0.64(0.00~0.23) | 72 | 0.00(0.00~7.27) | 11 | 0.00(0.00~0.00) | 0.00 | ||
检验报告不正确率 | 42 | 0.00(0.05~3.25) | 87 | 0.00(0.00~0.11) | 24 | 0.00(0.00~0.03) | 0.90 | ||
危急值通报率 | 45 | 100.00(94.41~100) | 82 | 100.00(95.82~100) | 21 | 100.00(95.38~100) | 0.60 | ||
危急值通报及时率 | 43 | 100.00(55.21~100) | 78 | 100.00(88.02~100) | 21 | 100.00(97.57~100) | 0.03 | ||
室内质控项目开展率 | 38 | 88.36(53.79~100) | 65 | 81.39(32.41~100) | 7 | 100.00(19.02~100) | 0.03 | ||
室内质控项目CV不合格率 | 37 | 0.00(0.00~9.95) | 62 | 0.00(0.00~19.50) | 6 | 0.00(0.00~0.00) | 0.13 | ||
室间质评项目参加率 | 37 | 100.00(83.99~100) | 57 | 100.00(84.21~100) | 7 | 100.00(50.00~100) | 0.86 | ||
室间质评项目不合格率 | 37 | 0.00(0.00~2.56) | 57 | 0.00(0.00~3.32) | 7 | 1.00(0.00~1.00) | 0.21 | ||
实验室间比对率 | 38 | 31.82(6.35~100) | 52 | 29.46(2.45~100) | 3 | 66.67(2.88~66.67) | 0.28 |
质量指标 | 三级医院 | 二级医院 | 二级以下医院 | P值 | |||||
---|---|---|---|---|---|---|---|---|---|
实验 室数(个) | P50(P5~P95) | 实验室数(个) | P50(P5~P95) | 实验室数(个) | P50(P5~P95) | ||||
标本类型错误率 | 46 | 0.00(0.00~0.06) | 91 | 0.00(0.00~0.13) | 24 | 0.00(0.00~0.29) | 0.29 | ||
标本容器错误率 | 46 | 0.00(0.00~0.05) | 91 | 0.00(0.00~0.10) | 24 | 0.00(0.00~0.11) | 0.01 | ||
标本采集量错误率 | 46 | 0.00(0.00~0.23) | 91 | 0.01(0.00~0.18) | 24 | 0.00(0.00~0.20) | 0.00 | ||
抗凝标本凝集率 | 46 | 0.05(0.01~1.07) | 89 | 0.03(0.00~0.60) | 24 | 0.00(0.00~0.85) | 0.01 | ||
血培养污染率 | 43 | 0.64(0.00~0.23) | 72 | 0.00(0.00~7.27) | 11 | 0.00(0.00~0.00) | 0.00 | ||
检验报告不正确率 | 42 | 0.00(0.05~3.25) | 87 | 0.00(0.00~0.11) | 24 | 0.00(0.00~0.03) | 0.90 | ||
危急值通报率 | 45 | 100.00(94.41~100) | 82 | 100.00(95.82~100) | 21 | 100.00(95.38~100) | 0.60 | ||
危急值通报及时率 | 43 | 100.00(55.21~100) | 78 | 100.00(88.02~100) | 21 | 100.00(97.57~100) | 0.03 | ||
室内质控项目开展率 | 38 | 88.36(53.79~100) | 65 | 81.39(32.41~100) | 7 | 100.00(19.02~100) | 0.03 | ||
室内质控项目CV不合格率 | 37 | 0.00(0.00~9.95) | 62 | 0.00(0.00~19.50) | 6 | 0.00(0.00~0.00) | 0.13 | ||
室间质评项目参加率 | 37 | 100.00(83.99~100) | 57 | 100.00(84.21~100) | 7 | 100.00(50.00~100) | 0.86 | ||
室间质评项目不合格率 | 37 | 0.00(0.00~2.56) | 57 | 0.00(0.00~3.32) | 7 | 1.00(0.00~1.00) | 0.21 | ||
实验室间比对率 | 38 | 31.82(6.35~100) | 52 | 29.46(2.45~100) | 3 | 66.67(2.88~66.67) | 0.28 |
质量指标 | P25 | P50 | P75 | |||||
---|---|---|---|---|---|---|---|---|
上海 | 全国 | 上海 | 全国 | 上海 | 全国 | |||
标本类型错误率 | 5.0 | 4.6 | 5.5 | 5.1 | 6.0 | 6.0 | ||
标本容器错误率 | 5.2 | 4.8 | 5.6 | 5.2 | 6.0 | 6.0 | ||
标本采集量错误率 | 5.0 | 4.5 | 5.3 | 4.9 | 6.0 | 6.0 | ||
抗凝标本凝集率 | 4.6 | 4.3 | 5.0 | 4.6 | 6.0 | 6.0 | ||
血培养污染率 | 3.6 | 3.3 | 4.2 | 4.1 | 6.0 | 6.0 | ||
检验报告不正确率 | 6.0 | 4.7 | 6.0 | 6.0 | 6.0 | 6.0 | ||
危急值通报率 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | ||
危急值通报及时率 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | ||
室内质控项目开展率 | 2.1 | 1.1 | 2.5 | 1.6 | 3.4 | 2.2 | ||
室内质控项目CV不合格率 | 3.3 | 2.7 | 6.0 | 3.8 | 6.0 | 6.0 | ||
室间质评项目参加率 | 6.0 | 2.5 | 6.0 | 6.0 | 6.0 | 6.0 | ||
室间质评项目不合格率 | 3.9 | 3.0 | 6.0 | 6.0 | 6.0 | 6.0 | ||
实验室间比对率 | 0.3 | 0.0 | 1.0 | 0.0 | 4.6 | 0.5 |
质量指标 | P25 | P50 | P75 | |||||
---|---|---|---|---|---|---|---|---|
上海 | 全国 | 上海 | 全国 | 上海 | 全国 | |||
标本类型错误率 | 5.0 | 4.6 | 5.5 | 5.1 | 6.0 | 6.0 | ||
标本容器错误率 | 5.2 | 4.8 | 5.6 | 5.2 | 6.0 | 6.0 | ||
标本采集量错误率 | 5.0 | 4.5 | 5.3 | 4.9 | 6.0 | 6.0 | ||
抗凝标本凝集率 | 4.6 | 4.3 | 5.0 | 4.6 | 6.0 | 6.0 | ||
血培养污染率 | 3.6 | 3.3 | 4.2 | 4.1 | 6.0 | 6.0 | ||
检验报告不正确率 | 6.0 | 4.7 | 6.0 | 6.0 | 6.0 | 6.0 | ||
危急值通报率 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | ||
危急值通报及时率 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | ||
室内质控项目开展率 | 2.1 | 1.1 | 2.5 | 1.6 | 3.4 | 2.2 | ||
室内质控项目CV不合格率 | 3.3 | 2.7 | 6.0 | 3.8 | 6.0 | 6.0 | ||
室间质评项目参加率 | 6.0 | 2.5 | 6.0 | 6.0 | 6.0 | 6.0 | ||
室间质评项目不合格率 | 3.9 | 3.0 | 6.0 | 6.0 | 6.0 | 6.0 | ||
实验室间比对率 | 0.3 | 0.0 | 1.0 | 0.0 | 4.6 | 0.5 |
项目 | 常规检验 | 急诊检验 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
实验室数(个) | 均值 | P5 | P50 | P95 | 实验室数(个) | 均值 | P5 | P50 | P95 | ||
生化 | |||||||||||
检验前 | 138 | 76.9 | 29.8 | 69.0 | 136.1 | 128 | 27.7 | 5.0 | 30.0 | 60.0 | |
实验室内 | 146 | 159.5 | 30.0 | 120.0 | 360.0 | 131 | 53.5 | 20.0 | 46.0 | 120.0 | |
自动化免疫 | |||||||||||
检验前 | 127 | 83.3 | 30.0 | 65.0 | 151.2 | 97 | 46.6 | 7.7 | 30.0 | 93.0 | |
实验室内 | 130 | 491.6 | 60.0 | 218.5 | 1 440.0 | 94 | 223.1 | 20.0 | 60.0 | 1 048.0 | |
三大常规 | |||||||||||
检验前 | 138 | 70.8 | 15.0 | 60.0 | 125.8 | 128 | 22.1 | 2.5 | 15.5 | 56.4 | |
实验室内 | 143 | 80.6 | 13.2 | 53.0 | 228.0 | 131 | 33.0 | 6.0 | 20.0 | 60.0 | |
凝血 | |||||||||||
检验前 | 120 | 69.0 | 20.2 | 60.0 | 141.0 | 113 | 27.2 | 5.0 | 23.0 | 70.2 | |
实验室内 | 124 | 99.3 | 22.0 | 82.5 | 224.8 | 117 | 45.1 | 17.8 | 41.0 | 91.0 |
项目 | 常规检验 | 急诊检验 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
实验室数(个) | 均值 | P5 | P50 | P95 | 实验室数(个) | 均值 | P5 | P50 | P95 | ||
生化 | |||||||||||
检验前 | 138 | 76.9 | 29.8 | 69.0 | 136.1 | 128 | 27.7 | 5.0 | 30.0 | 60.0 | |
实验室内 | 146 | 159.5 | 30.0 | 120.0 | 360.0 | 131 | 53.5 | 20.0 | 46.0 | 120.0 | |
自动化免疫 | |||||||||||
检验前 | 127 | 83.3 | 30.0 | 65.0 | 151.2 | 97 | 46.6 | 7.7 | 30.0 | 93.0 | |
实验室内 | 130 | 491.6 | 60.0 | 218.5 | 1 440.0 | 94 | 223.1 | 20.0 | 60.0 | 1 048.0 | |
三大常规 | |||||||||||
检验前 | 138 | 70.8 | 15.0 | 60.0 | 125.8 | 128 | 22.1 | 2.5 | 15.5 | 56.4 | |
实验室内 | 143 | 80.6 | 13.2 | 53.0 | 228.0 | 131 | 33.0 | 6.0 | 20.0 | 60.0 | |
凝血 | |||||||||||
检验前 | 120 | 69.0 | 20.2 | 60.0 | 141.0 | 113 | 27.2 | 5.0 | 23.0 | 70.2 | |
实验室内 | 124 | 99.3 | 22.0 | 82.5 | 224.8 | 117 | 45.1 | 17.8 | 41.0 | 91.0 |
[1] | 中华人民共和国国家卫生和计划生育委员会. 国家卫生计生委办公厅关于印发麻醉等6个专业质控指标(2015年版)的通知[Z]. 国卫办医函〔2015〕252号,2015-04-13. |
[2] | 王治国,费阳,康凤凤,等. 国家卫生计生委发布临床检验专业15项医疗质量控制指标(2015年版)内容及解读[J]. 中华检验医学杂志,2015,38(11):777-781. |
[3] | SCIACOVELLI L,PANTEGHINI M,LIPPI G,et al.Defining a roadmap for harmonizing quality indicators in laboratory medicine:a consensus statement on behalf of the IFCC Working Group 'Laboratory Error and Patient Safety' and EFLM Task and Finish Group' Performance specifications for the extra-analytical phases'[J]. Clin Chem Lab Med,2017,55(10):1478-1488. |
[4] | PLEBANI M.The quality indicator paradox[J]. Clin Chem Lab Med,2016,54(7):1119-1122. |
[5] | PLEBANI M,SCIACOVELLI L,AITA A.Quality indicators for the total testing process[J]. Clin Lab Med,2017,37(1): 187-205. |
[6] | 卫生部. 医疗机构临床实验室管理办法[Z]. 卫医发〔2006〕73号,2016-02-27. |
[1] | MENG Xi, WEI Zhen, BAI Jianhua, HAO Xiaoke, ZENG Xianfei. Application of EWMA,HIQC and autoverification in primary medical institutions [J]. Laboratory Medicine, 2023, 38(9): 884-889. |
[2] | TAN Chunyan, ZHOU Ying, MO Zhijiang. Errors in Appendix B examples of WS/T 505—2017 and correction [J]. Laboratory Medicine, 2023, 38(6): 569-573. |
[3] | CHEN Naihan, SA Yalian. Overview of detection methods for Mycoplasma in cell preparations [J]. Laboratory Medicine, 2022, 37(7): 684-687. |
[4] | OU Tong, ZHANG Bing, ZHANG Xiuming. Re-understanding about the rational application of clinical laboratory determination technologies for COVID-19 diagnosis [J]. Laboratory Medicine, 2022, 37(4): 303-308. |
[5] | ZHANG Chen, LI Ting, MENG Qinghao, XIE Nan, ZHANG Weimin, ZHAO Fei, LI Min, GAO Xuan, YANG Sijie. Performance evaluation of glycerol as stabilizer for the preparation of seminal plasma biochemical quality control products [J]. Laboratory Medicine, 2022, 37(12): 1200-1203. |
[6] | FANG Huiling, CHEN Ziqi, ZHU Yuqing. Performance of antigen test for SARS-CoV-2 and related research progress [J]. Laboratory Medicine, 2022, 37(11): 1098-1103. |
[7] | KAN Lijuan, ZHANG Lijun, ZHANG Xiuming. Interpretation and application of 15 quality control indicators in clinical laboratories [J]. Laboratory Medicine, 2022, 37(10): 907-914. |
[8] | YANG Fan, DONG Danfeng, LU Yide. Application of patient-based real-time quality control using exponentially weighted moving average method on internal quality control procedures for serum ion items [J]. Laboratory Medicine, 2021, 36(9): 962-968. |
[9] | JING Jie, WANG Beilei, LIU Shanrong. Explainable artificial intelligence in disease diagnosis and treatment [J]. Laboratory Medicine, 2021, 36(9): 976-980. |
[10] | CHEN Ping, CHEN Tingting. Establishment of clinical laboratory risk control system based on the ISO 15189 quality system [J]. Laboratory Medicine, 2021, 36(8): 869-874. |
[11] | ZHANG Pengyin, QUAN Jing, WANG Xueliang, XIAO Yanqun, BAO Yun. External quality assessment of irinotecan-related metabolism genotyping in Shanghai [J]. Laboratory Medicine, 2021, 36(8): 875-879. |
[12] | ZHANG Hongwei, ZHAO Zhengjie, ZHAO Yan, LI Haisheng, LI Xiufang, QIAN Jing, GUO Chong. Application of Unity Real Time software to establish individual quality control rules for blood cell analysis [J]. Laboratory Medicine, 2021, 36(7): 749-752. |
[13] | ZHENG Cuiling, WANG Li, CHENG Yan, CUI Wei. Fresh blood comparison program in daily internal quality control of hematology analyzers [J]. Laboratory Medicine, 2021, 36(6): 662-666. |
[14] | GE Danhong, TANG Liping, OU Yuanzhu, YU Xiaoxuan, LIU Wenbin, LIN Feiran, GONG Jingkai, ZHU Yuqing. Assessment of internal quality control plan for microfluidic chip POCT [J]. Laboratory Medicine, 2021, 36(6): 674-678. |
[15] | ZHAO Ran, LIU Wenbin, LIN Feiran, GONG Jingkai, YU Xiaoxuan, GE Danhong, TANG Liping, OU Yuanzhu. Internal quality control and evaluation of blood gas analysis based on Westgard sigma rules [J]. Laboratory Medicine, 2021, 36(5): 544-548. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||